Markets

Grid Transformation Unlocked: Laser Power & Infra IPO Set to Ignite India's Massive Energy Backbone Modernization The Indian power sector is undergoing a rapid evolution, transitioning from legacy infrastructure to cutting-edge grid solutions. The upcoming IPO of a key player in this space signals more than just a financial event; it represents a critical investment opportunity into the nation's future energy stability. This listing provides market participants a direct look at the burgeoning demand for robust power delivery systems—the very veins that pump life into India’s industrial growth engine.The company and its offering are central to the narrative of "powering from wire to tower," addressing the immense challenge of...

LMW Ltd Receives ESG Rating from CRISIL ESG Ratings & Analytics Limited LMW Ltd has announced that it received an Environmental, Social, and Governance (ESG) rating from CRISIL ESG Ratings & Analytics Limited (CRISIL ESG).The company reported the assignment of the ESG rating by CRISIL ESG. It was noted that LMW Ltd did not engage CRISIL ESG to undertake the assessment.CRISIL ESG assigned the rating independently, basing it on information available in the public domain.LMW Stock Price Movement As of 10:09 AM, LMW Limited shares are edging up to ₹15857, climbing 0.39% in live trading. The stock activity includes a total traded volume of 631 shares so far today.

Dr Reddy's Shares Plunge After Semaglutide Commercial Production Faces Delay Due to Active Ingredient Issue Dr Reddy's Laboratories saw a notable dip in its stock as the company announced a delay in the commercial production of semaglutide. The decline follows the announcement that certain batches of the vital metabolic therapy were found to be out of specification due to an issue related to the active pharmaceutical ingredient (API).The news immediately impacted market sentiment towards the pharmaceutical firm. Shares fell by 2% as investors digested the information regarding the supply chain and manufacturing hiccup for the important drug.Details of the Semaglutide Production Delay Dr Reddy's issued a formal statement confirming...

JSW Steel Reports Consolidated Crude Steel Production of 6.59 Million Tonnes for Q1 FY27 JSW Steel has reported its consolidated Crude Steel production figures for the first quarter (Q1) of the fiscal year 2026-27, noting a total production of 6.59 million tonnes. The company provided detailed breakdowns of operations across its domestic and international units.The Q1 FY27 performance data reflected varying growth rates across different operational segments. Domestic Indian Operations contributed 6.35 MnT to the consolidated figure, compared to 6.32 MnT in Q4 FY26 and 6.14 MnT in Q1 FY26. JSW Steel USA - Ohio produced 0.24 MnT in Q1 FY27, against 0.15 MnT in Q4 FY26 and 0.24 MnT in Q1 FY26.The consolidated production across all...

NCL Industries Reports Production and Dispatch Data for Quarter Ending June 30, 2026 NCL Industries Ltd has released its production and dispatch quantities for various products—including Cement, Cement Particle Boards, RMC, Doors, and Energy—for the quarter ended June 30, 2026. The data provides a detailed comparison against the same period in the previous year (Quarter Ended 30/06/2025).The company's operations saw diverse performance across its product lines. Cement production increased by 9%, reaching 692,914 MT in the quarter ending June 30, 2026, up from 634,256 MT in the previous year. Correspondingly, Cement Dispatches grew by 8%, standing at 680,547 MT compared to 628,384 MT during Quarter Ended 30/06/2025.In contrast...

Roselabs Finance Ltd Schedules Board Meeting to Approve Q1 Un-audited Financials Roselabs Finance Ltd has announced a meeting of its Board of Directors, which is scheduled to address and approve the company’s un-audited financial results for the quarter ended June 30, 2026.The Board meeting is set for Friday, July 17, 2026, where the management will review and formally approve the Un-audited Financial Results alongside the Limited Review Report for the specified period.In addition to the board agenda, Roselabs Finance Ltd confirmed that the trading window for all designated persons has been closed. This closure took effect from July 1, 2026, and will remain in place until 48 hours after the company declares its financial results...

Sensex Surges Over 450 Points as Value Buying and FII Inflows Anchor Market Recovery Equity markets witnessed a significant rebound on Wednesday, as both the Sensex and Nifty defied earlier sharp declines. The indices rose substantially, driven by fundamental value buying and robust foreign institutional investment (FII) flows. This recovery came amid heightened geopolitical tensions surrounding the Middle East region.Key Index Movements in Equity Markets The Indian equity markets opened positively on July 9, bouncing back from a major daily loss recorded in the previous session. The Sensex finished strong at 76,971.34, registering a gain of 467.74 points or 0.61%. Concurrently, the Nifty reached 24,018.40, marking an increase of...

Large-Caps Plunge Amid Geopolitical Jitters: Broad Selloff Forces Market Risk Reassessment The Indian equity market witnessed a sharp downturn on Wednesday, transforming what might have been a routine valuation reset into a broader risk-off event. While investors had anticipated some profit booking in overheated mid and small-cap stocks, the simultaneous selloff in large caps signalled significant underlying fear.A renewed escalation of geopolitical tensions over the Middle East has dominated market sentiment, triggering fresh worries about higher crude oil prices, persistent inflation, and reduced corporate earnings expectations.Largecaps Lead Widespread Market Decline The sharp decline was remarkably broad-based across major...

TCS Plunges Amid Skepticism Ahead of Q1 Results; Investors Await AI Strategy and Demand Revival Tata Consultancy Services (TCS) shares saw a significant downturn in early trade on Thursday, with investors focusing intensely on the company’s future trajectory rather than just its quarterly numbers. The stock declined sharply as it prepares to announce results for the fiscal first quarter (Q1 FY27). This movement underscores the market's demand for clarity regarding TCS's AI execution and the broader recovery of enterprise discretionary spending.TCS shares fell by up to 1.9 percent, reaching Rs 2,018.5 in early trading. The company’s stock has seen a substantial decline of 36.2 percent year-to-date, significantly outpacing the 8.7...

Rupee Holds Steady Amid Geopolitical Heat: Cautious Traders Await RBI Intervention as Oil Jitters Rise Currency Stays Flat as Crude Prices Reawaken Import Bill Concerns The Indian rupee opened flat today, trading at Rs 95.55 against the US dollar. This level is unchanged from its previous close. The market sentiment remains cautious as renewed geopolitical tensions in West Asia bring back concerns regarding India’s import bill and the current account deficit.In the preceding session, the local currency had seen a slip, reaching a one-month low. Today's flat trading reflects the global volatility driven by crude oil price movements and diplomatic escalations.Geopolitical Tensions Drive Renewed Volatility in Forex Market Oil price...

Dr. Reddy's Laboratories Reports Quality Issues with Semaglutide Batches, Announcing Supply Delays Dr. Reddy's Laboratories Limited has reported that certain batches of semaglutide have been found to be out of specification due to an issue related to the active pharmaceutical ingredient (API) used in the product. The company is actively investigating the root cause of this matter and implementing necessary measures to uphold product quality standards.The company stated that, while investigations are underway, commercial supplies of the semaglutide product will be delayed until the underlying issue has been fully resolved. Dr. Reddy's Laboratories reassured stakeholders that there is no impact on patient safety regarding the affected...

Bond Volatility Explodes: Global Oil Surge and US Rate Fears Pressuring Indian Government Securities Indian government bond yields are likely to face continued caution, potentially trending towards further declines as global commodity prices rise sharply. The pressure stems from elevated oil costs combined with heightened concerns over the future trajectory of U.S. interest rates.The 10-year benchmark yield is anticipated to trade between 6.73% and 6.79%, following a decisive move on Wednesday. This was preceded by a single-session rise of 7 basis points, marking the biggest increase in over three months for the bond.Global Headwinds Drive Yields Higher Oil prices experienced a surge on Wednesday, propelled by geopolitical...

Money Markets Absorb Nearly ₹74,000 Cr as RBI Sustains Tight Liquidity Management The Reserve Bank of India (RBI) released comprehensive operational data for the money markets on July 8, 2026. The report highlights significant liquidity absorption across the financial sector, indicating the central bank's focused efforts in stabilizing market conditions and managing overall systemic liquidity flow.Money Market Operations Reflect Tightening Trend The overnight money markets saw a total volume of ₹6,59,022.07 crore. This segment was heavily dominated by Triparty Repo operations, which accounted for ₹4,50,275.35 crore at a weighted average rate of 5.20%.In the Term Segment, volumes were also registered across various instruments. The...

Alpine Texworld to Raise ₹126 Cr in IPO, Fueling Major Capacity Expansion Gujarat-based textile manufacturer Alpine Texworld is gearing up for a significant market debut. The company is set to launch its Initial Public Offering (IPO) on July 14, marking the second mainboard IPO expected next week following SBI Funds Management’s offering.The listing provides investors with an opportunity to participate in a growing sector staple. Alpine Texworld aims to raise Rs 126.25 crore through this fresh issue of 1.2 crore equity shares. The offer size has been adjusted down from the initial plan, as noted in the draft red herring prospectus (DRHP) filed in September 2025.What Investors Need to Know About the Alpine Texworld IPO The public...

Honasa Consumer Projects Strong Q1 FY27 Performance, Targets Double-Digit Operating Margin Honasa Consumer Limited has provided an update on its operating performance for the quarter ended June 30, 2026 (Q1 FY27), anticipating a robust period as it begins fiscal year 2027. The company expects sustained growth across its portfolio, aiming to deliver a double-digit operating margin profile in Q1 FY27 aided by operational leverage from scale.The outlook for the quarter suggests strong Year-on-Year (YoY) growth opportunities. Overall business growth is expected to be around thirties during the quarter. When adjusting for the change in revenue recognition policy involving the Flipkart group, the company expects YoY growth to fall within...

Memory Giant CXMT Poised for Massive IPO Amid Global Chip Market Volatility Changxin Memory Technologies (CXMT), a leading player in the memory chip sector, is preparing to take its maiden listing at the Shanghai stock exchange. The company has announced plans to book-build its initial public offering (IPO) starting July 15, aiming to raise $4.34 billion, or 29.5 billion yuan.The mega IPO is expected to proceed rapidly, with investor subscriptions scheduled for July 16. CXMT’s listing comes as the global memory chip market navigates heightened volatility, raising questions about the sustainability of recent tech share surges.CXMT's Financial Surge and Market Position CXMT stands as the world's fourth-largest DRAM manufacturer...

Asian Development Bank Slashes India's FY27 Growth Forecast to 6.6% Amid High Energy Prices The Asian Development Bank (ADB) has revised its growth projection for the Indian economy in Fiscal Year 2027 (FY27), scaling it down to 6.6 percent from an earlier forecast of 6.9 percent. This recalibration comes as elevated oil and transportation costs begin to exert pressure on private demand and overall consumer sentiment, according to the ADB's latest Asian Development Outlook report.Impact of Energy Costs on Economic Growth Projections The primary driver for the reduction in growth outlook is the persistent impact of high energy prices. The ADB noted that these rising operational costs are weighing significantly on India's economic...

Nomura Doubles Down on Ather Energy: Retains 'Buy' Rating and Jumps Target Price to ₹1,470 Amid EV Inflection Point Nomura has significantly upgraded its outlook on Ather Energy, maintaining a "Buy" rating while raising its target price from Rs 1,120 to Rs 1,470. The brokerage declared Ather the "top pick to ride on EV inflection," driven by the growing market maturity and strong consumer interest within India's electric two-wheeler (EV) segment.Why Nomura Sees an Inflection Point in Indian EVs Nomura’s report underscores that the market is reaching a critical turning point for EV penetration in India. This surge is attributed to robust consumer enthusiasm, which is being strongly supported by supportive policies enacted by both the...

Energy In Motion Signs Deal with CATL to Secure 0.5 GWh Supply of LFP Cells Energy In Motion Limited (EIM), an associate company of Ravindra Energy Limited, has secured a significant supply partnership with Contemporary Amperex Technology Co., Limited (CATL). The agreement covers the provision of Lithium Iron Phosphate (LFP) cells and battery pack kits from CATL to EIM for use in India.Under the terms of the Letter of Agreement (LOA), CATL will supply 0.5 GWh of its LFP cells. These supplies utilize the upgraded CB7T0 cell model and the L324D06 battery pack platform. This latest technology is designed for heavy commercial vehicles and features notably higher cycle life and volumetric density compared to the previous CB230 cell model...

Biocon Publishes Pivotal Clinical Data Supporting Effectiveness of Yesafili Biosimilar for DME Biocon Limited, an innovation-led global biopharmaceutical company, has announced the publication of two critical clinical studies validating the effectiveness and safety of Yesafili™ (aflibercept-jbvf), a biosimilar to Eylea®. These publications contribute significantly to the clinical evidence base supporting aflibercept MYL-1701P for treating diabetic macular edema (DME).Yesafili™, which was granted interchangeable designation by the U.S. Food and Drug Administration in May 2024, is indicated for the treatment of Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (AMD), and Macular Edema Following Retinal Vein...